-
Weekly Roundup: $5 Beats Free, SunFunder Rises, and Asia’s Investors Love Impact
Why it's not crazy for a global health organization to refuse free vaccines, where the world's most socially conscious investors live, which major funder might be planning to alter some old investment restrictions, and what's needed to support the Sustainable Development Goals. That and more; it's all here in our Weekly Roundup.
- Categories
- Health Care
-
A ‘just-add-water’ kit to make instant drugs and vaccines could fix health care access in rural areas
A team of researchers at University of Toronto and Harvard University’s Wyss Institute for Biologically Inspired Engineering are ... pioneering a technology that could allow people with minimal training to produce a broad range of medication, including diagnostic tools, vaccines, and drugs, anywhere in the world.
- Categories
- Health Care
-
Thanks but no thanks: Why MSF is rejecting donated vaccines from Pfizer
Medecins Sans Frontieres announced Tuesday it will reject an offer of free pneumonia vaccine from pharmaceutical company Pfizer Inc, after the company declined to offer a more “sustainable and long-term” solution for acquiring the drug through discounted pricing, MSF officials told Devex.
- Categories
- Health Care
- Tags
- vaccines
-
The ‘Just Add Water’ Chemistry Kit Can Create On-Demand Drugs and Vaccines
As humans explore the furthest edges of our own planet and others, the old ways of developing drugs won't work forever. Spending years creating a drug, testing it, manufacturing massive amounts of it, and then moving the temperature-sensitive medication over hundreds of miles is agonizingly cumbersome. When a community in a remote region is devastated by a Zika outbreak, slow and expensive solutions can cost lives. With the populations of the world’s least-developed countries projected to double by 2050, getting medication to remote areas is of growing interest to doctors and scientists.
- Categories
- Health Care
- Tags
- vaccines
-
World’s First Dengue Vaccine Approved in Over 10 Countries
Sanofi-Pasteur, the vaccines global business unit of Sanofi, announced today that thedengue vaccines have received approval in 14 countries.
- Categories
- Health Care
- Region
- South Asia
-
New Freeze-Dried Vaccines Let You Just Add Water
Researchers at Harvard and MIT have developed a technique that allows the manufacturing of antimicrobial compounds, vaccines, and antibodies from freeze-dried DNA molecules. The technique could allow vaccines to be made on-site in locations that need them, just like mixing up a jug of Gatorade from some powder and water.
- Categories
- Health Care
- Tags
- vaccines
-
Sanofi gets $43 million U.S. funding to spur Zika vaccine development
Sanofi SA said on Monday the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.
- Categories
- Health Care
-
GSK Pledges to Drop Vax Price for Refugees
GlaxoSmithKline will discount the price of its pneumococcal vaccine to $3.05 per dose for charities which work to immunize refugees and displaced people. The price reduction for Synflorix is the first step in a broader pledge to supply essential vaccines to civil society organizations at lower prices.
- Categories
- Health Care
- Tags
- vaccines